ATE410146T1 - Poly(alkylenoxide) von reduziertem format mit reboxetin zur verringerung der bildung von verunreinigungen - Google Patents

Poly(alkylenoxide) von reduziertem format mit reboxetin zur verringerung der bildung von verunreinigungen

Info

Publication number
ATE410146T1
ATE410146T1 AT03747606T AT03747606T ATE410146T1 AT E410146 T1 ATE410146 T1 AT E410146T1 AT 03747606 T AT03747606 T AT 03747606T AT 03747606 T AT03747606 T AT 03747606T AT E410146 T1 ATE410146 T1 AT E410146T1
Authority
AT
Austria
Prior art keywords
reboxetine
poly
alkylene oxides
reduce impurities
reduced format
Prior art date
Application number
AT03747606T
Other languages
English (en)
Inventor
Sylvia Seroff
Noymi Yam
Atul Ayer
Andrew Lam
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE410146T1 publication Critical patent/ATE410146T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyethers (AREA)
AT03747606T 2002-04-29 2003-04-28 Poly(alkylenoxide) von reduziertem format mit reboxetin zur verringerung der bildung von verunreinigungen ATE410146T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37648102P 2002-04-29 2002-04-29

Publications (1)

Publication Number Publication Date
ATE410146T1 true ATE410146T1 (de) 2008-10-15

Family

ID=29401353

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03747606T ATE410146T1 (de) 2002-04-29 2003-04-28 Poly(alkylenoxide) von reduziertem format mit reboxetin zur verringerung der bildung von verunreinigungen

Country Status (11)

Country Link
US (1) US20040033263A1 (de)
EP (1) EP1503732B1 (de)
JP (1) JP4717436B2 (de)
KR (1) KR100887982B1 (de)
AR (1) AR039492A1 (de)
AT (1) ATE410146T1 (de)
AU (1) AU2003243172A1 (de)
CA (1) CA2483656C (de)
DE (1) DE60323964D1 (de)
TW (1) TWI343824B (de)
WO (1) WO2003092649A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
US20120070465A1 (en) 2010-03-29 2012-03-22 Astellas Pharma Inc. Pharmaceutical composition for modified release
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1156807A (fr) * 1953-12-28 1958-05-21 Hoechst Ag Procédé permettant de préparer des huiles et des cires chloro-fluoro-carbonées
BE557908A (de) * 1956-05-29
NL229031A (de) * 1957-06-27
US3135705A (en) * 1959-05-11 1964-06-02 Hercules Powder Co Ltd Polymeric epoxides
US3219591A (en) * 1958-05-29 1965-11-23 Hercules Powder Co Ltd Organoaluminum oxide catalyst composition
US3037943A (en) * 1958-12-29 1962-06-05 Union Carbide Corp Preparation of catalysts for the polymerization of epoxides
US3403114A (en) * 1967-02-17 1968-09-24 Hercules Inc Polymers of amino epoxides
US4097652A (en) * 1975-08-28 1978-06-27 Albany International Corp. Poly (ethylene oxide) monofilament
US4193892A (en) * 1976-11-11 1980-03-18 Union Carbide Corporation Process for preparing olefin oxide polymerization catalysts by aging the catalysts
US4169062A (en) * 1977-05-12 1979-09-25 Southern Sizing Co. Random copolymers of polyoxyethylene polyoxypropylene glycol monoester, process of making the same and textile fiber containing the same
US4267309A (en) * 1978-07-28 1981-05-12 Union Carbide Corporation Process for preparing olefin oxide polymerization catalysts
US4211681A (en) * 1978-08-16 1980-07-08 Union Carbide Corporation Poly(ethylene oxide) compositions
US4277366A (en) * 1979-09-26 1981-07-07 Union Carbide Corporation Poly(alkylene oxide) composition
JPS56104936A (en) * 1980-01-24 1981-08-21 Dai Ichi Kogyo Seiyaku Co Ltd Purification of polyether polyol
US4667013A (en) * 1986-05-02 1987-05-19 Union Carbide Corporation Process for alkylene oxide polymerization
US4946687A (en) * 1987-10-02 1990-08-07 Alza Corporation Dosage form for treating cardiovascular diseases
US5030456A (en) * 1988-11-07 1991-07-09 Alza Corporation Dosage form for treating cardiovascular diseases
US5216122A (en) * 1991-05-21 1993-06-01 Union Carbide Chemicals & Plastics Technology Corporation Removal of residual ethylene oxide from poly(ethylene oxide)
JP3073054B2 (ja) * 1991-07-11 2000-08-07 住友精化株式会社 アルキレンオキシド重合体の製造方法
WO1995034582A1 (en) * 1994-06-16 1995-12-21 Pharmacia S.P.A. Bioadhesive starches and process for their preparation
JP4730985B2 (ja) * 1997-09-10 2011-07-20 武田薬品工業株式会社 安定化された医薬製剤
UA56257C2 (uk) * 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Спосіб лікування неадекватної визивної поведінки
WO1999015177A1 (en) * 1997-09-23 1999-04-01 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
JP2001520195A (ja) * 1997-10-17 2001-10-30 イーライ・リリー・アンド・カンパニー 医薬の増強
SE9902364D0 (sv) * 1999-06-21 1999-06-21 Astra Ab New process
US6387403B1 (en) * 1999-09-15 2002-05-14 Alza Corporation Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
DK1385898T3 (da) * 2001-05-01 2006-10-02 Union Carbide Chem Plastic Farmaceutisk sammensætning omfattende poly(alkylenoxider) med reducerede mængder af myresyreforbindelser

Also Published As

Publication number Publication date
KR20050016374A (ko) 2005-02-21
US20040033263A1 (en) 2004-02-19
JP2005525406A (ja) 2005-08-25
DE60323964D1 (de) 2008-11-20
WO2003092649A3 (en) 2004-01-22
TW200400057A (en) 2004-01-01
EP1503732A2 (de) 2005-02-09
EP1503732B1 (de) 2008-10-08
JP4717436B2 (ja) 2011-07-06
CA2483656C (en) 2013-06-18
CA2483656A1 (en) 2003-11-13
KR100887982B1 (ko) 2009-03-09
TWI343824B (en) 2011-06-21
AR039492A1 (es) 2005-02-23
AU2003243172A1 (en) 2003-11-17
WO2003092649A2 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
DE60122077D1 (de) Verbundglasscheibe
DE60115095D1 (de) Fluorpolymerzusammensetzungen mit verbesserter gasdurchlässigkeit
DE60118801D1 (de) Polymermischung mit hohem brechungsindex
DE60237690D1 (de) Zellulares telefon mit kamera
DE60139473D1 (de) Polycarbonatdiol mit hohem anteil an primären terminalen oh
DE60229068D1 (de) Filterschaltung
DE60119064D1 (de) Säge mit Leuchtstofflampe
DE60200292D1 (de) Transparente Abrechnung von mehreren Anschlussnummern in drahtlosen Telefonsystemen
PL375265A1 (en) Polyalkylene glycol acid additives
DE60118476D1 (de) Fluoreszente Lampen mit hoher Farbwiedergabe
EP1143001A4 (de) Interferon-alpha
DE60235947D1 (de) Glas mit hohem unteren Kühlpunkt
DE60139339D1 (de) Stabilisierte interferonzusammensetzungen
ATE410146T1 (de) Poly(alkylenoxide) von reduziertem format mit reboxetin zur verringerung der bildung von verunreinigungen
DE60104299D1 (de) Fluoroelastomerzusammensetzung mit exzellenter verarbeitbarkeit
FI20012074L (fi) Tasasuuntauspiiri
DE60225266D1 (de) Zusammensetzung mit induzierendem kathartischen effekt
DE60210468D1 (de) Kabriolett mit versenkbarem dach
NO20025076L (no) Forbedret filtreringseffektivitet
DE60200581D1 (de) Filterschaltung
DK1451433T3 (da) Glassammensætning
EP1267898A4 (de) Gallensäure enthaltend propharmaka mit erhöhter bioavibilität
EP1501790A4 (de) Neue natriumkanalblocker
EP1575419A4 (de) Bildung von eisennitrosyl-hämoglobin
DE60232822D1 (de) Kompensationsschaltung mit trimmeffekt

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties